Sargent Bickham Lagudis’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
$230K Sell
2,537
-1,389
-35% -$126K 0.02% 255
2022
Q3
$298K Sell
3,926
-481
-11% -$36.5K 0.03% 214
2022
Q2
$373K Sell
4,407
-130
-3% -$11K 0.03% 203
2022
Q1
$398K Buy
4,537
+90
+2% +$7.9K 0.03% 198
2021
Q4
$389K Sell
4,447
-123
-3% -$10.8K 0.03% 190
2021
Q3
$374K Buy
4,570
+1,525
+50% +$125K 0.03% 189
2021
Q2
$278K Buy
3,045
+1,194
+65% +$109K 0.02% 222
2021
Q1
$158K Buy
1,851
+1,607
+659% +$137K 0.01% 276
2020
Q4
$23K Hold
244
﹤0.01% 540
2020
Q3
$21K Hold
244
﹤0.01% 501
2020
Q2
$21K Hold
244
﹤0.01% 482
2020
Q1
$20K Sell
244
-65
-21% -$5.33K ﹤0.01% 471
2019
Q4
$29K Buy
309
+62
+25% +$5.82K ﹤0.01% 468
2019
Q3
$21K Hold
247
﹤0.01% 471
2019
Q2
$23K Sell
247
-29
-11% -$2.7K ﹤0.01% 470
2019
Q1
$24K Sell
276
-334
-55% -$29K ﹤0.01% 488
2018
Q4
$47K Sell
610
-436
-42% -$33.6K 0.01% 373
2018
Q3
$81K Sell
1,046
-73
-7% -$5.65K 0.01% 302
2018
Q2
$76K Sell
1,119
-1,021
-48% -$69.3K 0.01% 306
2018
Q1
$155K Sell
2,140
-868
-29% -$62.9K 0.02% 236
2017
Q4
$226K Sell
3,008
-663
-18% -$49.8K 0.03% 202
2017
Q3
$282K Buy
3,671
+378
+11% +$29K 0.04% 178
2017
Q2
$246K Sell
3,293
-3
-0.1% -$224 0.03% 191
2017
Q1
$219K Sell
3,296
-511
-13% -$34K 0.03% 199
2016
Q4
$248K Sell
3,807
-358
-9% -$23.3K 0.04% 179
2016
Q3
$295 Buy
4,165
+494
+13% +$35 0.04% 169
2016
Q2
$271K Buy
3,671
+845
+30% +$62.4K 0.04% 173
2016
Q1
$183K Buy
+2,826
New +$183K 0.03% 214